Novel 4,5-diarylspiro[2.4]hept-5-enes, 6,7-diarylspiro[3.4]oct-6-enes,
and 2,3-diarylspiro[4.4]non-2-enes have been synthesized and shown to
be very potent inducible cyclooxygenase (COX-2) inhibitors with inhib
ition (IC50) in the low nanomolar range and enzyme selectivity ratios
as high as four orders of magnitude. The methyl sulfone spiro[2.4]hept
-5-ene 1 (SC-58451) was found to be orally active (ED(50) = 0.3 mpk) i
n the rat adjuvant-induced arthritis model with no gastric lesions obs
erved at 200 mpk.